H-VTSAPDTRPAPGSTAPPAHG-NH2
Ref. 3D-PP44176
Unbestimmte Größe | Nachfragen |
Produktinformation
- NH2-Val-Thr-Ser-Ala-Pro-Asp-Thr-Arg-Pro-Ala-Pro-Gly-Ser-Thr-Ala-Pro-Pro-Ala-His-Gly-amide
Peptide H-VTSAPDTRPAPGSTAPPAHG-NH2 is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using H-VTSAPDTRPAPGSTAPPAHG-NH2 include the following: Synthesis and antibody recognition of synthetic antigens from MUC1 Z Banoczi , G Mezacaµ , E Windberg, K Uray - Journal of Peptide , 2008 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1002/psc.950 Multivalent Protein Glycosylation: A Driving Force of Cancer Progression and Alzheimer's Disease Pathogenesis YN Singh - 2022 - search.proquest.comhttps://search.proquest.com/openview/44e075c36857a18b169b150d902e774c/1?pq-origsite=gscholar&cbl=18750&diss=y Structurally defined synthetic cancer vaccines: analysis of structure, glycosylation and recognition of cancer associated mucin, MUC-1 derived peptides X Liu, J Sejbal, G Kotovych, RR Koganty - Glycoconjugate , 1995 - Springerhttps://link.springer.com/article/10.1007/BF00731254 Random glycopeptide bead libraries for seromic biomarker discovery SK Kracun , E Clo, H Clausen , SB Levery - Journal of proteome , 2010 - ACS Publicationshttps://pubs.acs.org/doi/abs/10.1021/pr1008477 Expression of MUC1 and its significance in hepatocellular and cholangiocarcinoma tissue SF Yuan, KZ Li, L Wang, KF Dou, Z Yan - World Journal of , 2005 - ncbi.nlm.nih.govhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC4615407/ Retargeting of human T cells to tumor-associated MUC1: the evolution of a chimeric antigen receptor S Wilkie, G Picco, J Foster, DM Davies - The Journal of , 2008 - journals.aai.orghttps://journals.aai.org/jimmunol/article/180/7/4901/38447 Epitope characterization of MUC1 antibodies S Imai, S Haga, Y Kiyozuka - Tumor Biology, 1998 - karger.comhttps://karger.com/tbi/article-pdf/19/Suppl.%201/30/3566252/000056502.pdf Specificity analysis of sera from breast cancer patients vaccinated with MUC1-KLH plus QS-21 S Adluri, T Gilewski, S Zhang, V Ramnath - British journal of , 1999 - nature.comhttps://www.nature.com/articles/6690288 Stable one-step technetium-99m labeling of His-tagged recombinant proteins with a novel Tc (I)-carbonyl complex R Waibel, R Alberto , J Willuda, R Finnern - Nature , 1999 - nature.comhttps://www.nature.com/articles/nbt0999_897 Characterization of monoclonal antibody 436 recognizing the Arg-Pro-Ala-Pro sequence of the polymorphic epithelial mucin (PEM) protein core in breast carcinoma M Nuti, V Turchi, A Rughetti, P Viacava - journal of biological , 1992 - journals.sagepub.comhttps://journals.sagepub.com/doi/abs/10.1177/172460089200700201 Multiplexed detection of autoantibodies to glycopeptides using microarray JW Pedersen, A Nostdal, HH Wandall - Immunoproteomics: Methods and , 2019 - Springerhttps://link.springer.com/protocol/10.1007/978-1-4939-9597-4_12 Structural and dynamic consequences of increasing repeats in a MUC1 peptide tumor antigen JT Schuman, JS Grinstead - Biopolymers , 2005 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1002/bip.20190 Epitope mapping of antigenic MUC1 peptides to breast cancer antibody fragment B27. 29: a heteronuclear NMR study JS Grinstead, JT Schuman, AP Campbell - Biochemistry, 2003 - ACS Publicationshttps://pubs.acs.org/doi/abs/10.1021/bi0301237 Biologics through chemistry: total synthesis of a proposed dual-acting vaccine targeting ovarian cancer by orchestration of oligosaccharide and polypeptide domains J Zhu, Q Wan, G Ragupathi, CM George - Journal of the , 2009 - ACS Publicationshttps://pubs.acs.org/doi/abs/10.1021/ja810147j Correlation of MUCIN1 immunohistochemical expression and MUCIN1 expression immunoreactivity pattern on histopathological grading of prostate J Sahmulia, LI Laksmi, JS Lukito - Correlation of MUCIN1 , 2021 - scholar.archive.orghttps://scholar.archive.org/work/4m6qduhf7jc5xixhuh6shiboxy/access/wayback/https://www.ijrp.org/filePermission/fileDownlaod/4/969d7ab28d358677fccbe8706226fc78/6 A fucose residue can mask the MUC-1 epitopes in normal and cancerous gastric mucosae J Bara, A Imberty , S Perez , K Imai - journal of cancer, 1993 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1002/ijc.2910540414 Cancer associated aberrant protein O-glycosylation can modify antigen processing and immune response CB Madsen, C Petersen, K Lavrsen, M Harndahl - PloS one, 2012 - journals.plos.orghttps://journals.plos.org/plosone/article?id=10.1371/journal.pone.0050139 Cancer Associated Aberrant Protein O-Glycosylation Can Modify Antigen Processing CB Madsen, C Petersen, K Lavrsen, M Harndahl - 2012 - academia.eduhttps://www.academia.edu/download/71402003/Cancer_Associated_Aberrant_Protein_O-Gly20211005-8386-1bm7nel.pdf Chemical and enzymatic methods to improve biodistribution of fac-M (HâââO) ââÆ (CO) ââÆâº(M= â¹â¹Tc, â¹â¹mTc, and RE) labeled proteins and peptides A Stichelberger - 2002 - research-collection.ethz.chhttps://www.research-collection.ethz.ch/bitstream/handle/20.500.11850/146969/1/eth-25939-01.pdf Chemical and Enzymatic Methods to Improve Biodistribution of fac-[M (H2O) 3 (CO) 3](M= 99Tc, 99mTc, and Re) Labeled Proteins and Peptides A STICHELBERGER - 2002 - Citeseerhttps://citeseerx.ist.psu.edu/document?repid=rep1&type=pdf&doi=3238ab636c8025c1caa1c78ab939581630282885 Chemo-Enzymatic Production of O-Glycopeptides for the Detection of Serum Glycopeptide Antibodies A Nostdal, HH Wandall - Immunoproteomics: Methods and Protocols, 2013 - Springerhttps://link.springer.com/protocol/10.1007/978-1-62703-589-7_10
Chemische Eigenschaften
Technische Anfrage zu: 3D-PP44176 H-VTSAPDTRPAPGSTAPPAHG-NH2
Wenn Sie ein Angebot anfordern oder eine Bestellung aufgeben möchten, legen Sie stattdessen die gewünschten Produkte in Ihren Warenkorb und fordern Sie dann ein Angebot oder eine Bestellung an aus dem Warenkorb. Es ist schneller, billiger und Sie können von den verfügbaren Rabatten und anderen Vorteilen profitieren.